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Forced degradation studies of gliquidone were conducted under different stress conditions. Three 
degradates were observed upon using HPLC and TLC and elucidated by LC-MS and IR. HPLC method 
was performed on C18 column using methanol-water (85:15 v/v) pH 3.5 as a mobile phase with isocratic 
mode at 1 mL.min-1 and detection at 225 nm. HPLC analysis was applied in range of 0.5-20 µg.mL-1 
(r =1) with limit of detection (LOD) 0.177 µg.mL-1. TLC method was based on the separation of 
gliquidone from degradation products on silica gel TLC F254 plates using chloroform-cyclohexane-
glacial acetic acid (6:3:1v/v) as a developing system with relative retardation 1.15±0.01. Densitometric 
measurements were achieved in range of 2 -20 µg /band at 254 nm (r = 0.9999) with LOD of 0.26 µg /band.  
Least squares regression analysis was applied to provide mathematical estimates of the degree of 
linearity. The analysis revealed a linear calibration for HPLC where a binomial relationship for TLC. 
Stability testing and methods validation have been evaluated according to International Conference on 
Harmonization guidelines. Moreover, the proposed methods were applied for the analysis of tablets 
and the results obtained were statistically compared with those of pharmacopeial method revealing no 
significant difference about accuracy and precision. 
Keywords: Gliquidone/forced degradation/stability-indicating. HPLC/method validation. TLC/method 
validation.
INTRODUCTION 
Gliquidone is 1, 1-cyclohexyl-3-{4-[2-(3, 4-dihydro-
7-methoxyy-4, 4-dimethyl-1, 3- dioxo-2 (1H) - isoquinolyl) 
ethyl benzene sulphonyl]} urea. It is a sulfonylurea 
derivative used as oral anti-diabetic drug for the treatment 
of type 2 diabetes mellitus. The drug is given as a 
supplemental therapy followed by diet modification and 
improves the glycemic control as well as reducing 
the blood sugar level (Brayfield, 2014). Gliquidone is 
official in BP(Brithish Pharmacopeia, 2016). Literature 
survey revealed that quantitation of gliquidone has been 
achieved by UV spectrophotometry (Arayne, Sultana, 
Mirza, 2006), LC-MS (Maurer et al., 2002) and HPLC 
in dosage form and biological fluids (Arayne et al., 
2010a; Arayne et al., 2010b; Guo et al., 1992; Sridevi, 
Diwan, 2000). Recently, spectrofluoremetric normal and 
derivative synchronous methods have been published for 
the determination of gliquidone in drug substance and drug 
products (El-Ghobashy et al., 2018). To date, no stability 
-indicating method has been described in the literature and 
no previous studies focused on gliquidone degradation 
have been performed. As per regulatory requirements for 
registration of new drugs, stress degradation should be 
applied. Therefore, forced degradation studies involving 
gliquidone will increase the chemical information about the 
degradation products of active pharmaceutical ingredients 
in both pure and pharmaceutical forms (Görög, 2000) 
offering a scientific impact for the present novel work. In 
addition, the stress testing to identify the degradation of the 
molecule can be further used to develop stability-indicating 
methods of analysis (FDA, 2000). A stability-indicating 
method accurately measures the changes in active ingredient 
concentration without interference from other degradation 
products, impurities and excipients (ICH, 2003a).
The goals of the present study are: i) to perform a 
forced degradation study of gliquidone according to the 
ICH guidelines; ii) to elucidate the chemical structure 
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of the degradation products; iii) to develop and validate 
HPLC and TLC methods able to quantify the drug even in 
the presence of the its degradation products. 
EXPERIMENTAL 
Material and chemicals 
Drug substance, gliquidone working standard 
(99.36%) was kindly supplied by Mina Pharm Company, 
Cairo, Egypt. Drug product, Glorenor® tablets, batch No. 
EIE2313 Mina pharm under license of Menarini –Italy 
labeled to contain 30 mg gliquidone per each tablet and 
was purchased from commercial sources in the local 
market. HPLC grade methanol (Macron Poland), ethanol 
(Sigma Aldrich, USA), water-in house was bi-distilled. 
Chloroform (Sigma Aldrich), cyclohexane (S.D. fine-chem 
limited, Mumbai, India), glacial acetic acid (Piochem 
Egypt). Sodium hydroxide extra pure 98 % (Lobachem 
Mumbai, India), hydrochloric acid 37% (Honeywell) and 
hydrogen peroxide 30% (Panreac) were analytical grade. 
b. Instrumentation and chromatographic conditions 
For HPLC: an HPLC system (Agilent Technology 
1260 series, USA) equipped with G1314F UV detector, 
G1311C quaternary pump, G1316A column oven, Agilent 
1260 series vacuum degasser, and 20 microliter loop 
manual injector was used. HPLC separation and analysis 
were performed on C18, 250 mm × 4.6 mm, 10 µm, column 
(Phenomenex®, USA). The mobile phase consisted of 
methanol and water pH 3.5 adjusted with ortho-phosphoric 
acid (85:15 v/v) using a pH meter (Jenway 3510, England). 
An isocratic elution with a flow rate of 1 mL.min-1 was kept 
throughout the analysis and the detection was achieved 
at 225 nm. The column was conditioned for ≥30min at 
ambient temperature (25 ± 2 °C). Data were recorded and 
analyzed by Chemstation® software (Agilent, USA). A 
mixture of methanol-water in the ratio of (85: 15 v/v) was 
used as a diluent for the working solutions. All solutions 
were filtered through 0.45 mm nylon membrane filter 
before HPLC injections.
For TLC- densitometry: CAMAG scanner 3 plus and 
CAMAG TLC sampler linomat IV (CAMAG, Multenz, 
Switzerland) supplied with a 100 µL syringe for TLC- 
densitometric determinations. The following parameters 
were taken into consideration; slit dimension: 6×0.3 mm; 
scanning speed: 20mm/s; data resolution: 100 µm/step; 
bandwidth: 6 mm. Results output: chromatograms and 
integrated peak areas of WINCATS software. TLC aluminum 
plates (20×10) were coated with 0.25 mm silica gel 60 F254 
(Merck, Germany) and chloroform - cyclohexane -glacial 
acetic acid (6:3:1v/v) was used as a developing system. 
For LC- MS: an Agilent technology 6420 triple 
Quad LC/MS consisting of a G1311A gradient quaternary 
pump, G1329A auto injector, and the G6420A MS 
detector was employed. HPLC separation was performed 
on C18, 60×4.6 mm, 5 μm, column (BD, USA). The 
mobile phase consisted of a mixture of acetonitrile 
and acidified water (0.075% formic acid) at a flow rate 
0.7 mL.min-1 (Table I). Nitrogen and gas temperature 
of 270 °C with a flow of 10 liter/min and nebulizer of 
50 pounds per square inch (psi) were used. The ionization 
mode was ESI and the data were analyzed by Mass 
Hunter® software.
For IR spectroscopy: NICOLET 6700, FT - IR 
Thermo SCIENTIFIC - CLASS 1 LASER PRODUCT 
(USA) using KBr disc, Mini - Pellet Press and OMNIC 
software for data output.
Preparation of degradation product and stock 
standard solutions
Acid hydrolytic degradation 
Gliquidone (50 mg) was refluxed for 9 hours with 
different concentrations of 50 mL ethanolic hydrochloric 
acid (1M; 2M; 3M; 4M) and the same concentration 
was left in 0.1-3 M ethanolic hydrochloric acid at room 
temperature for 3 days. After this period, each solution was 
neutralized, filtered, evaporated using a water bath, and 
had the volume reconstituted with methanol to produce 
concentration equivalent to 1 mg.mL-1. 
Base hydrolytic degradation
Gliquidone (50 mg) was refluxed for 9 hours 
with distinct concentrations of 50 mL ethanolic sodium 
hydroxide (1 M; 2 M; 3 M; 4 M) and the same concentration 
was left in 0.1-3 M ethanolic sodium hydroxide at room 
temperature for 3 days. After this period, each solution was 
neutralized, filtered, evaporated using a water bath, and 
had the volume reconstituted with methanol to produce 
concentration equivalent to 1 mg.mL-1. 
TABLE I - Gradient elution of LC-MS mobile phase
Time (min)
Mobile phase composition (%)
Acetonitrile Acidified water
2.57 13 87
2.66 35 65
7.71 35 65
7.80 50 50
16.29 50 50
16.36 75 25
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Neutral hydrolytic degradation 
50 mg of gliquidone was refluxed with 50 mL of 
bi-distilled water for 5 hours and filtered, evaporated 
using water bath and completed to volume with methanol 
(1 mg.mL-1).
Oxidative degradation 
50 mg of gliquidone was refluxed with 50 mL of 
30% hydrogen peroxide for 5 hours, filtered, evaporated 
using a water bath and completed to volume with methanol 
(1 mg.mL-1).
Thermal degradation 
100 mg of gliquidone in solid state was spread 
to 1 mm thickness in a Petridish and kept in the oven 
(Memmert UM-400, Germany) at 40 °C and 80 °C for 
4 hours. 10 mg of each sample was taken into 10-mL 
volumetric flask, dissolved and diluted with methanol. 
Stress degradation studies 
From hydrolytic, oxidative and thermal degradation 
solutions (1 mg.mL-1), different aliquots were transferred 
into 10-mL volumetric flasks and diluted to the mark with 
methanol for the primary trials. Samples were analyzed by 
HPLC and TLC in order to evaluate the stability of intact 
drug towards these stress conditions. The basic hydrolytic 
degradation was analyzed by LC-MS. Moreover 
degradation solution was applied in bands on silica gel 
glass plates and developed in chloroform -cyclohexane - 
glacial acetic acid (6:3:1 v/v). Each of the isolated bands 
was extracted from silica with methanol, air dried and IR 
spectra were scanned. All collected samples were kept in 
refrigerator at 5 °C ± 2.
Standard stock solutions
For HPLC, Gliquidone 0.2 mg.mL-1 was prepared 
in methanol; further dilution with the diluent to obtain a 
solution of 20 µg.mL-1. For TLC, Gliquidone 1 mg.mL-1 
was prepared in methanol.
Laboratory prepared mixtures solutions containing 
different ratios of gliquidone and its alkaline degradation 
products were prepared to contain 10- 80% w/w of alkaline 
degradation for HPLC and TLC.
Preparation of calibration curves
HPLC method
Aliquots of standard solution 20 µg.mL-1 equivalent 
to 5-200 µg of gliquidone were transferred into a series of 
10-mL volumetric flasks, and the volume was completed 
with the diluent. Triplicate injections of each dilution 
were eluted at flow rate 1mL.min-1 on a C18 column using 
methanol – water at pH 3.5 adjusted with ortho-phosphoric 
acid (85/15 v/v) as the mobile phase. The integrated 
peak areas were recorded at 225 nm under the specified 
chromatographic conditions. Calibration curve was 
prepared by plotting peak areas versus the concentration 
0.5- 20 μg.mL-1 and the regression equation was computed. 
TLC-densitometric method
Aliquots of standard solution 1 mg.mL-1 equivalent to 
2 to 20µg/band were spotted on precoated TLC plates using 
CAMAG linomat IV applicator under a nitrogen stream. 
The procedure was carried out as under “Instrumentation 
and chromatographic conditions” and plates were developed 
for up to 8 cm at room temperature in a chromatographic 
chamber previously saturated for 30-45 minutes. The 
plates were air dried and densitometric measurements 
were performed at 254nm in absorbance mode with the 
CAMAG TLC scanner 3 as under the specified instrumental 
conditions. The calibration curve was prepared by plotting 
the peak areas versus the concentration 2-20 µg/band and 
regression equation was computed.
Assay of Glorenor® tablets
Using HPLC method
Twenty tablets were accurately weighed, crushed to 
a fine powder. An accurately weighed portion equivalent 
to 60 mg of gliquidone was transferred to 250-mL 
beaker, extracted with 40 mL methanol by shaking for 
30 min using an ultrasonic bath (sonamac), filtered into 
100-mL volumetric flask and diluted to volume with the 
same solvent. Further dilution  with the HPLC diluent to 
obtain an 18 µg.mL-1 solution. The procedure detailed 
under “preparation of calibration curve “was followed 
and gliquidone concentration was calculated using the 
corresponding regression equation.
Using TLC-densitometric method
Aliquots of the same tablets solution (60 mg.100 mL-1) 
covering the working concentration range were spotted and 
the procedure under “preparation of calibration curve” was 
performed and gliquidone concentration was calculated 
using the corresponding regression equation.
RESULTS AND DISCUSSION 
Results of forced degradation studies 
The results of stability study were confirmed by 
HPLC, TLC and three degradates were observed and 
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elucidated by LC-MS analysis and IR-spectroscopy. 
Gliquidone was found to be stable under thermal conditions 
at 40 °C and 80 °C for 4 hours (data not show). Partial 
degradation was observed under neutral hydrolytic and 
oxidative (30% H2O2) conditions for 5 hours (Figure 1a-b). 
Significant degradation was observed in 0.1 M-3 M 
ethanolic HCl or ethanolic NaOH at room temperature 
for 3 days or refluxing for 7 hours (data not show). A 
complete degradation of gliquidone was produced only 
upon using 4 M ethanolic HCl and 4 M ethanolic NaOH 
under reflux for 9 hours and the same peaks were observed 
in both conditions as shown in Figure 1c, d. The solutions 
were subjected to HPLC and TLC analysis to establish the 
number of products formed. The chromatographic profiles 
of the degradation products formed under 4 M ethanolic 
HCl and 4 M ethanolic NaOH conditions are presented in 
Figure 1c-d, respectively. In both conditions peaks with 
same retention time were obtained.
Elucidation of the degradation products 
LC/MS analysis: solution of base degradation was 
subjected to LC-MS analysis and mainly 3 degradation 
products were detected. Suggested chemical formula and 
m/z were C8H12N2O2S (200.26) degradate I, C41H40N4O9S 
(764.84) degradate II and C20H25N3O4S (403.49) 
degradate III. Gliquidone and suggested degradates 
structures were shown in Figure 2a, b, c and d.
IR spectra (Cross, 1964): IR spectrum of degradate I 
Figure 2b, C=O amide stretching; cyclohexyl groups; 
gem-dimethyl groups and CH-stretching at 2857 cm-1 
of - O -CH3 were absent ,but 3467 (NH stretching), 1648 
(NH bend), 1560 (NH bend, indicate – SO2NH) and 
11332,1165 (S=O stretch) were present. The main groups 
of gliquidone IR spectrum Figure 2a, were observed in 
degradate II and suggested to form a more conjugated 
molecule Figure 2c. The presence of NH- stretching 
FIGURE 1 - Original chromatograms of a) neutral hydrolytic degradation, b) oxidative degradation, c) acid hydrolytic degradation, 
d) base hydrolytic degradation and e) intact gliquidone (G) (20 µg.mL-1) with retention time 5.8 minutes.
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at 3502 cm-1; NH-amide at 1649 cm-1; C=O at 1713, 
1676 cm-1; NH-bend at 1558 cm-1 indicate - SO2NH- 
sulfonamide group; S=O stretching at 1338 cm-1; and 
cyclohexyl groups of 2930, 1456, 1260 cm-1 were an 
indication of degradate III Figure 2d. 
Methods development 
HPLC method
Stability-indicating HPLC method has been, 
optimized, developed, and validated for the separation and 
determination of gliquidone in presence of degradation 
products Figure 1(a-e). The three components of HPLC 
method: column type, mobile phase composition and 
aqueous phase pH were studied and asymmetry was a 
function of judgment. The optimum ratio of mobile phase 
composition was found to be methanol - water (85:15 v/v). 
Water with pH value 3.5 offered a good symmetry, this 
pH is about 1 pH unit below pKa of the acidic drug (4.3) 
hence the uncharged form is obviously predominant 
and high retention on C18 stationary phase is observed. 
Working at a more acidic pH has an unfavorable effect 
on column lifetime; therefore pH 3.5 was optimized 
for peak symmetry and column capacity of gliquidone. 
Moreover, C18 column phenomenex® 10µm 250×4.6mm 
improves the peak shapes and resolution of gliquidone 
and its degradation products Figure 1(a-e). The gliquidone 
(Rt = 5.9±0.03 min) and the degradation products 
(I: Rt = 2.26 min; II: Rt = 2.58 min; III = 2.91 min) were 
detected at the maximum wavelength of absorption 
FIGURE 2 - LC-MS, suggested structures and IR spectra of a) gliquidone, b) degradate I, c) degradate II and d) degradate III.
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(225 nm). Final conditions: 20 microliter injection volume, 
1 mL.min-1 flow rate, 25 °C temperature, phenomenex® 
C18 (250 mm×4.6 mm I.d., 10µ particle diameters) and 
methanol- water pH 3.5 (85/15 v/v) were found to be ideal 
for HPLC performance.
TLC method
TLC-densitometric method was developed for the 
resolution of gliquidone from its degradation products on 
TLC aluminum plates, coated with silica gel 60 F254 as a 
stationary phase Figure 3b. The best developing system 
was found to be chloroform, cyclohexane and glacial acetic 
acid in the ratio of (6:3:1v/v) showing Rf values 0.60±0.01 
for gliquidone, and 0.01±0.01, 0.24±0.01, 0.52±0.01 for 
the degradation products I, II, III respectively Figure 3a 
and the calculated relative retardation factor (Rret) was 
found to equal 1.15±0.01, revealing a good separation of 
the drug from its degradation products. Different scanning 
FIGURE 3 - a) 2D TLC-densitogram of separated peaks of gliquidone (Rf 0.60±0.01) and the 3 degradation products (Rf degradate. 
I 0.01±0.01, degradate. II 0.24±0.01, degradate. III 0.0.52±0.01) and b) 3D TLC densitogram of gliquidone Rf (0.6±0.01) in the 
concentration range (2-20 µg/band), and a mixture of gliquidone and the 3 degradation products using (chloroform-cyclohexane-
glacial acetic acid) (6:3:1v/v) as a developing system at 254 nm.
Forced degradation of gliquidone and development of validated stability-indicating HPLC and TLC methods
Braz. J. Pharm. Sci. 2018;54(3):e00223 Page 7 / 10
wavelengths were tested (225,254 and 312) to obtain good 
sensitivity with minimum noise. The slit dimensions of the 
scanning light beam should ensure complete coverage of 
band dimensions without interference of the adjacent band 
and 6×0.3 mm was proved to be the slit dimension of choice 
that provided highest sensitivity and scanning at wavelength 
254 nm. Gliquidone was successfully resolved from its 
degradation products upon using the mentioned conditions.
Method validation 
The suggested HPLC and TLC methods were 
validated according to ICH guidelines (ICH, 2003b) for 
specificity, linearity, accuracy, precision and robustness to 
demonstrate that the developed procedures are sensitive, 
selective, accurate, precise and suitable for their intended 
use and to be used for QC analysis of gliquidone in drug 
substance and pharmaceutical product.
Specificity
Specificity could be demonstrated by the resolution 
of gliquidone and its degradation products as shown in 
representative HPLC Figure 1a-e and TLC Figure 3a-b 
Chromatograms. The presented HPLC and TLC methods 
were specific for identification and quantification of 
gliquidone in tablets without interference of excipients 
namely lactose, starch, pregelatinized starch and 
magnesium stearate (Torrinomedica, 2015). 
Linearity/range 
Linearity was established by analysis of samples 
in concentration range 0.5-20 µg.mL-1 by HPLC and 
2 - 20 µg/band by TLC. For HPLC method, the linear 
relationship in the concentration range was evaluated by 
calculation of the regression line by the method of least 
squares Figure 4a. However, for TLC method, regression 
data were statistically analyzed and found to be binomial 
regression to provide mathematical estimates of the degree 
of linearity Figure 4b. Correlation coefficient, y intercept, 
slope of the regression line and the residual sum of squares 
were listed in Table II.
FIGURE 4 - a) HPLC linear relationship between peak areas and gliquidone (1-20 µg.mL-1) and b) binomial relationship between 
peak areas and gliquidone (2-20 µg/band).
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Accuracy
Drug substance was analyzed using 3 concentrations 
of 9 determinations (2, 10, 18 µg.mL-1) for HPLC and 
(4, 10, 16 µg/band) for TLC methods Table II. The drug 
product was assayed by HPLC and TLC methods and 
standard added technique was applied to demonstrate 
the accuracy of the methods. The results were expressed 
as percent recovery ±%RSD. The calculated student’s 
t-test and the variance ratio F- test revealed no significant 
difference between the performance of both HPLC and 
TLC and the official method for tablets regarding accuracy 
and precision and the results were abridged in Table III 
(Agarwal, 2013).
Precision
The intra-day variability was assessed considering 
three concentration levels prepared in triplicate: 6, 10, and 
14 µg.mL-1 and 8, 10, and 12 µg/band for the HPLC and 
TLC methods, respectively. Intermediate precision was 
determined by analyzing the same concentrations n=9 for 
HPLC and for TLC on three successive days to estimate 
inter-day variation. Precision results were expressed for 
each type as %RSD as shown in Table II. The precision of 
instruments was checked by repeated measurement of the 
concentration (10 µg.mL-1) for HPLC and (10 µg/band) 
for TLC for 6 times. %RSD for measured peak areas by 
both HPLC and TLC procedures was found to be 0.536 
and 0.477, respectively. These values are bellow of that 
considered adequate (1%) to ensure proper functioning of 
HPLC and TLC systems.
LOD and LOQ 
LOD and LOQ were calculated for both HPLC and 
TLC procedures by the method based on the standard 
deviation σ of the response and the slope S of the calibration 
curve using the following formula: LOD = 3.3 σ/S and 
LOQ=10 σ/S and results are given in Table II.
Robustness
The robustness of analytical HPLC and TLC 
procedures is a measure of its capacity to remain unaffected 
by small but deliberate variation. For HPLC method the 
following parameters were tested: pH of mobile phase 
±0.1; mobile phase composition ±1 %, different C18 
columns (suppliers), column temperature 25±2 ̊C, flow 
rate ±0.05 and wavelength ±1. For TLC method: different 
plates (lots), developing system composition ±1 % and 
scanning wavelength ±2. Negligible difference was found 
in %RSD of response (0.56-1.65 for HPLC, 0.15-0.58 for 
TLC). Moreover, robustness of the proposed methods was 
concerned with the stability of solutions for 2 weeks and 
extraction time 10 - 30 min.
System suitability testing
System suitability parameters were evaluated. ICH 
states that system suitability testing is an integral part 
TABLE II - Performance data and validation parameters developed for HPLC and TLC methods
Characteristic parameter HPLC TLC
Range 0.5-20 µg.mL-1 2-20µg/band
Slope 81.708 543.58 for x 
11.392 for x2
SD of slope 0.176 ------
Intercept -0.143 4742.3
SD of intercept 2.018 ------
Correlation coefficient (r) 1 0.9999
LOD 0.177µg.mL-1 0.261µg/band
LOQ 0.537µg.mL-1 0.791µg/band
Residual sum of squares 117.485 ------
Accuracy (%recovery ± %RSD) 
Drug substance 
Drug product
 
99.305±0.997 
103.304±0.514
 
99.991±1.055 
102.799±0.579
Precision (%RSD) 
Intra-day 
Inter-day 
Precision of instruments
 
0.867 
1.812 
0.536
 
1.158 
1.444 
0.477
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TABLE III - Determination of gliquidone in pharmaceutical formulation by the proposed HPLC and TLC, application of the standard 
added technique and statistical comparison
Item Taken µg.mL-1 Found µg.mL-1 %Recovery %Comparison method (Brithish Pharmacopeia, 2016)
HPLC method 1.8 
5.4 
10.8 
18
1.869 
5.540 
11.147 
18.636
103.85 
102.61 
103.21 
103.53
103.20 
103.18 
102.85 
103.48
Mean x̅ ± SD 103.30 ± 0.530 103.180 ± 0.256
SE 0.265 0.128
t-test 0.408 (2.45)
F-test 4.32 (9.28)
Standard added to 5.4 µg.mL-1 2.7 
5.4 
10.8
2.660 
5.319 
10.657
98.54 
98.49 
98.68
TLC method 3.6 
6 
8.4 
12 
18
3.705 
6.114 
8.673 
12.404 
18.460
102.92 
101.89 
103.25 
103.36 
102.56
Mean x̅ ± SD 102.80 ± 0.595
SE 0.266
t-test 1.287 (2.36)
F-test 5.446 (9.12)
Standard added to 6 µg/band 3 
6 
12
2.943 
5.945 
11.900
98.131 
99.081 
99.172
Figures between parenthesis are the tabulated t and F- values (at degree of freedom=4 for comparison method, =4 for HPLC and 
=5 for TLC methods) at p=0.05 (B.L.Agarwal, 2013).
of the chromatographic procedures.Capacity factor (k̀), 
asymmetry factor, resolution (Rs), selectivity (α) and 
number of theoretical plates (N) were calculated for HPLC 
(United States Pharmacopeia, 2016) and TLC (Variyar, 
Chattyie, Sharma, 2011) methods and the results are given 
in Table IV. 
TABLE IV - System suitability parameters of HPLC and TLC methods developed for the determination of gliquidone
Parameter HPLC TLC Reference value
Capacity factor (K̀) 1.8 0.613 1-10 for HPLC 
0-10 for TLC
Resolution (Rs) 4.423 1.344 Rs > 1
Selectivity (α) 1.35 1.281 >1
Symmetry factor 0.99 1 ̴ 1
Height HETP(cm/plate ) 0.007 0.004 The smaller the value the higher the efficiency
Number of theoretical plates 3445.7 1128.96 Increase with efficiency of separation
Retardation factor ± SD 5.9±0.031 0.60±0.01
CONCLUSION
Stability studies of gliquidone revealed its stability 
in thermal conditions and partially degraded under acid 
and base hydrolysis on cold, neutral hydrolysis and 
oxidation conditions. The drug was completely degraded 
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in acid and base hydrolytic conditions when refluxed for 
9 hours. Results of HPLC and TLC showed the formation 
of mainly 3 detectable degradation products in acid and 
base media. The induced degradates were confirmed 
by LC - MS analysis and IR spectroscopy. Hence 
chromatographic techniques introduce a high separation 
power in pharmaceutical field so; HPLC and TLC have 
been developed for the separation of gliquidone and its 
degradation products. The cited methods were applicable 
for assay and purity testing of gliquidone in drug substance 
and drug product without interference of tablet excipients. 
The results obtained indicate that the introduced HPLC 
and TLC methods represent the sensitive, accurate, precise 
and rapid stability-indicating assays for gliquidone. 
Moreover, can be classified among the highly selective 
procedures and contribute to QC routine analysis.
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